Literature DB >> 10365005

Time course of neurone-specific enolase and S-100 protein release during and after coronary artery bypass grafting.

F Gao1, D N Harris, S Sapsed-Byrne.   

Abstract

Serum neurone-specific enolase (NSE) and S-100 protein are well established as markers of cerebral injury, and have been used as markers of neuronal and glial cell damage, respectively, after cardiac surgery with cardiopulmonary bypass (CPB), but the speed of their increase during CPB has not been studied. Therefore, we have investigated the time course of NSE and S-100 release during and after CPB. We studied 18 adult patients undergoing elective coronary artery bypass grafting (CABG). Standard hypothermic (32 degrees C) pulsatile bypass with membrane oxygenation was used. Blood samples were obtained at induction, before bypass, before rewarming, at the end of rewarming, 10 min, 1 h and 8 h after bypass and 1, 2 and 3 days after surgery. NSE and S-100 were assayed using immunoradiometric assay kits (Sangtec Medical). NSE and S-100 release followed similar time courses. Both increased sharply during bypass, reached peak concentrations at the end of rewarming (mean 25.55 (SEM 2.79) and 1.65 (0.23) microgram litre-1, respectively), had decreased significantly by the end of operation and returned to pre-bypass concentrations by the second day after surgery. No patient developed a major neurological deficit. When using NSE and S-100 assays to study cerebral dysfunction in relation to CPB, postoperative samples miss peak (end-bypass) concentrations, and studies should be designed to include intraoperative samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365005     DOI: 10.1093/bja/82.2.266

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  6 in total

1.  N-Acetylcysteine is ineffective on short-term neuron-specific enolase levels following coronary artery bypass graft surgery.

Authors:  Engin H Ugur; Nihan Yapici; Turkan Kudsioglu; Sinem Y Ugur; Mehmet F Yapici; Ayten Saracoglu; Kemal T Saracoglu; Zuhal Aykac
Journal:  J Anesth       Date:  2012-02-22       Impact factor: 2.078

2.  Bispectral index predicts deaths within 2 weeks in coma patients, a better predictor than serum neuron-specific enolase or S100 protein.

Authors:  Wenli Miao; Yuanxin Zhang; Hailing Li
Journal:  J Anesth       Date:  2013-08-11       Impact factor: 2.078

3.  Effects of pulsatile minimal invasive extracorporeal circulation on fibrinolysis and organ protection in adult cardiac surgery-a prospective randomized trial.

Authors:  Angelika Graßler; Robert Bauernschmitt; Irene Guthoff; Andreas Kunert; Markus Hoenicka; Günter Albrecht; Andreas Liebold
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

Review 4.  S100 and S100β: biomarkers of cerebral damage in cardiac surgery with or without the use of cardiopulmonary bypass.

Authors:  Shi-Min Yuan
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Oct-Dec

5.  Cardiac, renal, and neurological benefits of preoperative levosimendan administration in patients with right ventricular dysfunction and pulmonary hypertension undergoing cardiac surgery: evaluation with two biomarkers neutrophil gelatinase-associated lipocalin and neuronal enolase.

Authors:  José Luis Guerrero-Orriach; Daniel Ariza-Villanueva; Ana Florez-Vela; Lourdes Garrido-Sánchez; María Isabel Moreno-Cortés; Manuel Galán-Ortega; Alicia Ramírez-Fernández; Juan Alcaide Torres; Concepción Santiago Fernandez; Isabel Navarro Arce; José María Melero-Tejedor; Manuel Rubio-Navarro; José Cruz-Mañas
Journal:  Ther Clin Risk Manag       Date:  2016-04-21       Impact factor: 2.423

Review 6.  Current Evidence Regarding Biomarkers Used to Aid Postoperative Delirium Diagnosis in the Field of Cardiac Surgery-Review.

Authors:  Paweł Majewski; Małgorzata Zegan-Barańska; Igor Karolak; Karolina Kaim; Maciej Żukowski; Katarzyna Kotfis
Journal:  Medicina (Kaunas)       Date:  2020-09-24       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.